DXTX MEDICAL INC

DXTX Medical Inc specializes in manufacturing radio-frequency coils for MRI systems. These coils are designed for specific diagnostic imaging purposes, including endorectal, endocavitary, and disposable variants tailored for anatomical regions like the cervix, prostate, and colon. Their products are built to integrate with major MRI platforms from companies such as Philips, Siemens, and GE Healthcare.

DXTX Medical Inc is based in the United States. Since the company operates domestically, its devices must comply with U.S. regulatory requirements, such as those enforced by the FDA. Additionally, because the company’s products are listed in the FDA’s 510(k) and UDI databases, they are subject to U.S. medical device classification and authorization processes. However, if these devices are marketed internationally, they would also need to meet the regulatory standards of those countries.

DXTX Medical Inc’s devices are listed in the EU’s eudamed registry, as well as the FDA’s 510(k) and UDI databases. These listings indicate that the company’s products have undergone regulatory scrutiny in both the European Union and the United States. Listing in eudamed ensures visibility in the EU’s medical device transparency system, while inclusion in the FDA’s 510(k) and UDI databases confirms compliance with U.S. requirements for device classification and traceability. This helps healthcare providers, regulators, and distributors verify the authorized status of these devices.

DXTX Medical Inc’s MRI coils are classified under different regulatory tiers depending on their design and intended use. Most of their products fall under Class I (generally low-risk devices) or Class II/IIa (moderate-risk devices requiring additional scrutiny). The classification determines the regulatory pathway for authorization, such as whether a 510(k) clearance (in the U.S.) or CE marking (in the EU) is required. Class II/IIa devices often involve more rigorous testing and documentation to ensure safety and performance before market authorization.